Delving into the Latest Updates on Wuxi Sinotide New Drug Discovery Institutes with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Nervous System Diseases

Cardiovascular Diseases

Mesenchymal stem cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Mesenchymal stem cell therapy	1

主要目的：评价IHS002 HUC-MSC在烧伤创面和慢性创面（糖尿病足溃疡、压疮）患者中单次给药和多次给药的安全性和耐受性。次要目的：1）初步探索IHS002 HUC-MSC给药剂量，初步评价IHS002 HUC-MSC促进创面愈合的有效性，为后续临床试验的给药剂量提供依据。2）评价IHS002 HUC-MSC的免疫原性。探索性目的：初步探索IHS002 HUC-MSC局部给药的药代动力学。

[Translation]

Primary objective: To evaluate the safety and tolerability of single and multiple administrations of IHS002 HUC-MSC in patients with burn wounds and chronic wounds (diabetic foot ulcers, pressure sores). Secondary objectives: 1) To preliminarily explore the dosage of IHS002 HUC-MSC, preliminarily evaluate the effectiveness of IHS002 HUC-MSC in promoting wound healing, and provide a basis for the dosage of subsequent clinical trials. 2) To evaluate the immunogenicity of IHS002 HUC-MSC. Exploratory objective: To preliminarily explore the pharmacokinetics of local administration of IHS002 HUC-MSC.

Start Date12 Jul 2024

Sponsor / Collaborator

Wuxi Sinotide New Drug Discovery Institutes

100 Clinical Results associated with Wuxi Sinotide New Drug Discovery Institutes

Login to view more data

0 Patents (Medical) associated with Wuxi Sinotide New Drug Discovery Institutes

Login to view more data

100 Deals associated with Wuxi Sinotide New Drug Discovery Institutes

Login to view more data

100 Translational Medicine associated with Wuxi Sinotide New Drug Discovery Institutes

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 28 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data